Daiichi Sankyo U.S. CEO Joe Pieroni: An Interview With "The Pink Sheet" DAILY (Part 1 of 2)
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo's head of U.S. operations Joe Pieroni sat down with "The Pink Sheet" DAILY recently at the firm's U.S. headquarters in Parsippany, N.J., to discuss the company's cardiovascular products and pipeline and how the Japanese pharma is looking to the U.S. market as a core growth driver. Pieroni was tapped to lead the newly formed U.S. subsidiary in 2005 following the merger of Daiichi and Sankyo. Previously, Mr. Pieroni had launched Sankyo's U.S. commercial operations, first as president of the Sankyo Parke-Davis joint venture and then as president of Sankyo Pharma Inc., a wholly owned U.S. subsidiary.